Stay updated on Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The NIH funding note 2016 ( U.S. NIH Grant/Contract ) was added to the study metadata, and the page revision was updated to v3.6.6 (replacing v3.6.5).
    Difference
    0.1%
    Check dated 2026-08-29T19:10:24.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays the full study record for NCT03222856, replacing the prior error page and including the study overview, eligibility criteria, and locations.
    Difference
    64%
    Check dated 2026-08-15T15:12:05.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5 instead of Revision: v3.6.4, reflecting a small version update.
    Difference
    0.0%
    Check dated 2026-08-08T10:48:54.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now displayed, replacing Revision: v3.6.3. This update seems to be a site version update rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-07-25T05:27:57.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed, replacing Revision: v3.6.2. This indicates a version update for the page/system rather than a content addition or removal.
    Difference
    0.0%
    Check dated 2026-07-03T21:46:38.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.6.2 replaces v3.6.0 on the page, representing a minor update to the page's version tag. It does not change the displayed study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-06-26T19:38:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.